Synopsis: Filing its audited consolidated results for Q4 and full year FY2026 on 12 May 2026, Vinati Organics Limited posted consolidated net profit of Rs. 443.74 crore for the year, up 9.5 percent over FY2025, despite revenue declining marginally ,a gap explained entirely by operating margin expansion of roughly 360 basis points. The board recommended a final dividend of Rs. 8.50 per share and the group enters FY2027 with zero consolidated borrowings.
Shares of a leading specialty organics and chemicals manufacturer came into focus on 12 May 2026 as its board approved audited consolidated results for Q4 FY2026 and the full financial year ended 31 March 2026. The headline numbers on a consolidated basis: revenue essentially flat, profit up 9.5 percent, a result that the market will read as a margin-expansion story rather than a volume recovery. The board also announced a final dividend of Rs. 8.50 per share, payable subject to shareholder approval at the 37th Annual General Meeting.
With a market capitalization of Rs. 13,359.39 crore, the shares of Vinati Organics Limited were last trading at Rs. 1,288.7 per share, down 1.95 percent from its previous closing price of Rs. 1,314.3 apiece. It is trading at a P/E of 30.7.
For Q4 FY2026, consolidated revenue from operations came in at Rs. 603.92 crore, down 6.9 percent from Rs. 648.46 crore in Q4 FY2025. The sequential picture is considerably better: Q4 revenue was up 13.8 percent over Q3 FY2026’s Rs. 530.78 crore, indicating a meaningful volume uptick as the fiscal year closed. Consolidated net profit for Q4 stood at Rs. 123.86 crore essentially flat year-on-year against Rs. 123.04 crore in Q4 FY2025, but up 22.8 percent from Rs. 100.83 crore in Q3 FY2026. EPS for the quarter was Rs. 11.95.
For the full year FY2026, consolidated revenue from operations was Rs. 2,226.89 crore against Rs. 2,248.17 crore in FY2025, a marginal year-on-year decline of 0.9 percent. Net profit grew from Rs. 405.25 crore in FY2025 to Rs. 443.74 crore, a gain of 9.5 percent. Full-year consolidated EPS rose to Rs. 42.80 from Rs. 39.09 the prior year.
The operating margin is where the FY2026 story resides. On a consolidated basis, EBITDA expanded from approximately Rs. 581 crore (25.8 percent of revenue) in FY2025 to roughly Rs. 654 crore (29.4 percent) in FY2026 an improvement of around 360 basis points on a flat revenue base. This kind of margin expansion without a revenue tailwind typically reflects either a product mix shift toward higher-value offerings, input cost deflation, or both. The company has not disaggregated its financials by product line in this filing.
On the segment front, Vinati Organics reports its entire operations as a single segment manufacturing of chemicals under Ind AS 108. No further segment-level revenue or margin breakdown is available in this filing. The group’s four entities include the holding company, Veeral Organics Private Limited (India, antioxidants), Vinati Organics USA Inc., and the Atulya Vinod Saraf Foundation.
The gap between full-year standalone PAT (Rs. 487.78 crore) and consolidated PAT (Rs. 443.74 crore), approximately Rs. 44 crore reflects losses being absorbed at the subsidiary level, predominantly Veeral Organics, which remains in an investment and capacity ramp-up phase. The auditors note that the US subsidiary contributed revenue of Rs. 11.05 crore and net profit of Rs. 1.48 crore for the year, rendering it a negligible drag; the Rs. 44 crore net gap is therefore almost entirely attributable to Veeral Organics.
Dividend Announcement
The board has recommended a final dividend of Rs. 8.50 per equity share of face value Re. 1 each (850 percent) for FY2026, an increase over the Rs. 8.00 per share paid for FY2025. Payment is contingent on shareholder approval at the 37th AGM, with disbursement due within 30 days of that meeting’s conclusion. At the last recorded price of Rs. 1,507, this implies a trailing dividend yield of approximately 0.56 percent a modest yield that is consistent with the company’s longstanding preference for reinvestment over income distribution, with a three-year payout ratio of around 19 percent.
Balance Sheet Highlights
The consolidated balance sheet at 31 March 2026 is debt-free: borrowings stand at zero, compared to Rs. 62.63 crore at March 2025. Total consolidated equity grew to Rs. 3,161.68 crore from Rs. 2,793.28 crore, driven by retained earnings. Capital expenditure continues on the manufacturing side: gross block expanded from Rs. 1,723.65 crore to Rs. 2,121.63 crore, while capital work-in-progress fell from Rs. 438.15 crore to Rs. 214.09 crore, confirming that a substantial portion of prior-year capex has been commissioned and moved into operating assets.
Consolidated net cash from operating activities was Rs. 557.90 crore for FY2026, a strong conversion rate relative to the consolidated PAT of Rs. 443.74 crore, confirming that the earnings improvement is backed by actual cash generation and not working capital manipulation.
Business Overview
Incorporated in 1989, Vinati Organics Limited manufactures specialty organic intermediaries and monomers at its facilities in Mahad and Lote Parashuram in Maharashtra. The company is among the world’s largest producers of ATBS (2-Acrylamido-2-methylpropane sulfonic acid) and IBB (isobutyl benzene), with a customer base spanning specialty chemicals, polymers, pharmaceuticals, and agrochemicals globally.
ROCE stands at 20.6 percent and ROE at 15.8 percent on a trailing basis. Promoters hold 74.29 percent of the company, a position unchanged over the past year, while domestic institutional investors have raised their stake from 7.30 percent at March 2024 to 9.84 percent by December 2025: steady accumulation through a period of stock price softness.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Vinati Organics FY26 Profits Rise 9.5% to ₹443 Cr; Board Recommends ₹8.50 Dividend appeared first on Trade Brains.